Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis

Overview of attention for article published in Orphanet Journal of Rare Diseases, August 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,901 followers.

@castillobuiles @Boldizar "We aimed to analyze the long-term efficacy and safety of sirolimus therapy for LAM with 4-year follow-up... Adverse events related to sirolimus were mild." https://t.co/rulnu0XQak

05 Oct 2022

Reply Repost Favourite

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis https://t.co/GZsBICBb0F

11 Sep 2019

Reply Repost Favourite

A look at the long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis #RareDisease https://t.co/wLrhu7SGSz

28 Aug 2019

Reply Repost Favourite

New from #acmedsci https://t.co/4TEPLv9Dym Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis

28 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.